News

Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...
Sun Pharma shares surged after a settlement with Incyte over Leqselvi, a drug for severe hair loss. The agreement includes a ...
Press Trust of India on MSN17h
Sun Pharma shares climb nearly 3 pc
Shares of Sun Pharmaceutical Industries climbed nearly 3 per cent on Tuesday after the firm said it has inked a settlement pact with US-based Incyte Corporation regarding Leqselvi, a drug used for ...
MUMBAI: India’s equity benchmarks snapped a four-session losing streak on Tuesday, as lower-than-expected domestic inflation ...
The drug is indicated for the treatment of alopecia areata - a condition in which the immune system attacks hair follicles, ...
India's equity indices ended a four-session decline, as inflation data came in lower than anticipated, increasing hopes for ...
Equity benchmarks ended a four-day losing streak with modest gains on Tuesday, as easing CPI inflation lifted investor sentiment. Hopes of a potential rate cut spurred buying interest, pushing all NSE ...
The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.
Shares of HDFC Life Insurance, HDB Financial, ICICI Lombard, Just Dial will remain in focus as companies will declare Q1 ...
Foreign investors turned net buyers in Indian equities on Tuesday after heavy selling a day prior, while domestic ...